Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Orexigen Insists Revised Contrave Data Should Not Affect Timing Of NDA

This article was originally published in The Pink Sheet Daily

Executive Summary

FDA tells the biotech corrections to secondary endpoint data for one pivotal study for its diet pill filing comprise only a clinical amendment.

You may also be interested in...



Contrave Advisory Committee Date May Give Orexigen Late-Mover Advantage

Earlier panel critiques of Contrave rivals should provide insight on how FDA is weighing risk versus benefit in obesity space.

Contrave Advisory Committee Date May Give Orexigen Late-Mover Advantage

Earlier panel critiques of Contrave rivals should provide insight on how FDA is weighing risk versus benefit in obesity space.

Medivation, Orexigen Highlight Late-Stage Strategies for Closely-Watched Drugs

Medivation will push on with Phase III trials despite an Alzheimer's failure, while Orexigen says a competitor's obesity drug could affect partnering plans.

Related Content

Topics

UsernamePublicRestriction

Register

PS070487

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel